Qualigen Therapeutics, Inc.
QLGN
$1.90
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -97.43% | 202.58% | 227.04% | 27.36% | -76.80% |
| Total Receivables | 10.89% | 54.90% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -62.26% | 139.18% | 50.78% | -9.63% | -39.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.26% | 102.53% | 332.82% | -46.73% | -14.02% |
|
|
|||||
| Total Current Assets | -39.26% | 102.53% | 332.82% | -46.73% | -14.02% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | -39.24% | 102.62% | 332.82% | -46.73% | -50.66% |
|
|
|||||
| Total Accounts Payable | -2.39% | -4.29% | -11.62% | 2.92% | -18.97% |
| Total Accrued Expenses | 23.44% | -69.76% | -39.41% | 13.97% | 47.90% |
| Short-term Debt | -- | -- | -14.12% | 63.26% | -21.27% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -14.56% | -67.10% | 127.75% | -59.42% | 1,294.49% |
| Total Other Current Liabilities | -14.56% | -67.10% | 127.75% | -59.42% | 1,294.49% |
| Total Current Liabilities | 40.19% | -54.93% | -7.45% | 6.35% | 9.38% |
|
|
|||||
| Total Current Liabilities | 40.19% | -54.93% | -7.45% | 6.35% | 9.38% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -14.12% | 63.26% | -21.27% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 40.19% | -54.93% | -7.45% | 6.35% | 9.38% |
|
|
|||||
| Common Stock & APIC | 2.41% | -0.03% | 3.38% | 0.71% | 0.54% |
| Retained Earnings | -2.15% | -0.70% | -1.49% | -1.33% | -1.74% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.15% | -41.87% | 49.95% | -21.47% | -67.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -50.61% | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -50.61% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.15% | -41.87% | 49.95% | -21.47% | -67.41% |
| Total Preferred Equity | -50.61% | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -98.76% | 225.13% | 49.95% | -21.47% | -67.41% |
|
|
|||||